Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Senescence and immortality in hepatocellular carcinoma.
Ozturk M, Arslan-Ergul A, Bagislar S, Senturk S, Yuzugullu H. Ozturk M, et al. Among authors: yuzugullu h. Cancer Lett. 2009 Dec 1;286(1):103-13. doi: 10.1016/j.canlet.2008.10.048. Epub 2008 Dec 12. Cancer Lett. 2009. PMID: 19070423 Free article. Review.
Genome-wide transcriptional reorganization associated with senescence-to-immortality switch during human hepatocellular carcinogenesis.
Yildiz G, Arslan-Ergul A, Bagislar S, Konu O, Yuzugullu H, Gursoy-Yuzugullu O, Ozturk N, Ozen C, Ozdag H, Erdal E, Karademir S, Sagol O, Mizrak D, Bozkaya H, Ilk HG, Ilk O, Bilen B, Cetin-Atalay R, Akar N, Ozturk M. Yildiz G, et al. Among authors: yuzugullu h. PLoS One. 2013 May 15;8(5):e64016. doi: 10.1371/journal.pone.0064016. Print 2013. PLoS One. 2013. PMID: 23691139 Free PMC article.
Evaluation of ATAD2 as a Potential Target in Hepatocellular Carcinoma.
Ekin U, Yuzugullu H, Ozen C, Korhan P, Bagirsakci E, Yilmaz F, Yuzugullu OG, Uzuner H, Alotaibi H, Kirmizibayrak PB, Atabey N, Karakülah G, Ozturk M. Ekin U, et al. Among authors: yuzugullu h. J Gastrointest Cancer. 2021 Dec;52(4):1356-1369. doi: 10.1007/s12029-021-00732-9. Epub 2021 Nov 5. J Gastrointest Cancer. 2021. PMID: 34738187
Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers.
Hydbring P, Wang Y, Fassl A, Li X, Matia V, Otto T, Choi YJ, Sweeney KE, Suski JM, Yin H, Bogorad RL, Goel S, Yuzugullu H, Kauffman KJ, Yang J, Jin C, Li Y, Floris D, Swanson R, Ng K, Sicinska E, Anders L, Zhao JJ, Polyak K, Anderson DG, Li C, Sicinski P. Hydbring P, et al. Among authors: yuzugullu h. Cancer Cell. 2017 Apr 10;31(4):576-590.e8. doi: 10.1016/j.ccell.2017.03.004. Cancer Cell. 2017. PMID: 28399412 Free PMC article.
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors.
Goel S, Wang Q, Watt AC, Tolaney SM, Dillon DA, Li W, Ramm S, Palmer AC, Yuzugullu H, Varadan V, Tuck D, Harris LN, Wong KK, Liu XS, Sicinski P, Winer EP, Krop IE, Zhao JJ. Goel S, et al. Among authors: yuzugullu h. Cancer Cell. 2016 Mar 14;29(3):255-269. doi: 10.1016/j.ccell.2016.02.006. Cancer Cell. 2016. PMID: 26977878 Free PMC article.
13 results